{
    "2020-03-23": [
        [
            {
                "time": "",
                "original_text": "A股一季报首亏比例上升，海外市场业绩“受伤”亏损",
                "features": {
                    "keywords": [
                        "A股",
                        "一季报",
                        "首亏",
                        "海外市场",
                        "业绩",
                        "亏损"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "海外"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【面包财报】沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "营业总收入",
                        "净利润"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：2019年营业总收入11.21亿元，净利润1.42亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "营业总收入",
                        "净利润"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：全年扣非净利仅增6%，13价肺炎疫苗或成业绩爆发点",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "全年",
                        "扣非净利",
                        "增长",
                        "13价肺炎疫苗",
                        "业绩爆发点"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "专注于自主产品 云南沃森生物2019年营收增长近三成",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2019年",
                        "营收增长",
                        "自主产品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物2020一季度亏损超1800万元，2019年不分红 亏损",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2020一季度",
                        "亏损",
                        "2019年",
                        "不分红"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}